Deceptive Advertising! Claims Novo in GLP-1 Lawsuit Fallout
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Unlock ways to earn travel points on no fee cards. Boost your rewards and make the most of your travel expenses effortlessly.
17,323 articlesTwo pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Zircuit Finance unveils an institutional-grade on-chain yield vault designed to deliver 8-11% APR, combining cross-ch...
AI spending is roaring as hyperscale cloud providers expand data-center capacity. This article highlights two stock i...
Alphabet has quietly been reshaping the AI race. This article breaks down which segment is growing fastest, why it ma...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
When tech stocks wobble, the DOW often holds steady. This article explains why the DOW can beat Nasdaq today, what dr...
A single headline can move stock in moments, but the real story is rarely a simple one. This article dives into why a...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
As Ituran gears up for its 2025 earnings, investors want clarity on growth, margins, and cash flow. This guide breaks...
In a high-stakes New Mexico trial, Mark Zuckerberg argues that Facebook and Instagram are not designed to be addictiv...
A billionaire activist investor is stepping in with a bold move on Pinterest. This deep dive breaks down what this co...
A Wharton analysis finds Social Security dampens wealth inequality, but solvency risks and policy changes could erode...